BioCentury
ARTICLE | Clinical News

Hematopoietic stem cells: Started Phase III study

October 29, 2001 8:00 AM UTC

Nexell Therapeutics Inc. (NEXL), Irvine, Calif. Product: Hematopoietic stem cells Business: Gene/Cell therapy Therapeutic category: Cell replacement Target: NA Description: Hematopoeitic stem cells de...